PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

Where we at?, page-117

  1. 5,078 Posts.
    lightbulb Created with Sketch. 660
    Irrespective as to who buys, why is nobody buying this if results are so good?? I’d say that most heavy retail investors do more DD and knows more about a stock than funds do anyway. Funds just have the ability to put up a lot more money than retail. Some people need to stop trying to come up with excuses as to why the sp is where it is to justify their investment and just see it for what it is. It’s down over 90% and it’s not just bcos of the war, inflation, interest rates or bcos funds haven’t bought into this.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.